In a landmark three-day strategic dialogue held in early March 2025, the Kingdom of Belgium and the World Health Organization (WHO) convened to reinforce their long-standing partnership. As the global health landscape undergoes rapid, often turbulent, transformation, this high-level meeting served as a critical nexus for aligning Belgium’s development cooperation priorities with the WHO’s 14th General Programme of Work (GPW14).
The delegation, led by H.E. Christophe Payot, Ambassador of Belgium to the United Nations and other international organizations in Geneva, included representatives from Belgium’s Federal government as well as the Flemish and Walloon regional governments. Their mission was clear: to evaluate the efficacy of past collaborations, address emerging biological and geopolitical threats, and forge a cohesive path forward for universal health coverage (UHC) and equitable access to medical countermeasures.
Main Facts: The Pillars of the Partnership
The dialogue was built upon three core thematic pillars that define the current trajectory of international public health:
- Universal Health Coverage (UHC) and Health Systems Strengthening: Ensuring that populations—particularly in partner countries—have access to essential services without financial hardship.
- Equitable Access to Medical Countermeasures: Focusing on the sustainable production and distribution of vaccines, medicines, and health technologies.
- Health Emergencies and Pandemic Preparedness: Navigating the "new normal" of increased zoonotic threats, biological risks, and the imperative for a robust, multisectoral "One Health" approach.
This strategic alignment is not merely diplomatic; it is operational. By integrating WHO’s global technical expertise with Belgium’s targeted bilateral funding, the partnership seeks to create a multiplier effect, turning policy into tangible results in countries ranging from the Democratic Republic of Congo (DRC) to Senegal and Mozambique.
Chronology: A Three-Day Odyssey of Strategy and Review
The dialogue, conducted from March 2 to March 5, 2025, was structured to facilitate both high-level political consensus and granular technical review.
Day One: Foundations and Regional Realignment
The inaugural sessions focused on the shifting global health architecture. Ambassador Payot and the Belgian delegation engaged with WHO leadership to discuss how to harmonize Belgium’s development priorities with the WHO’s strategic directions. This session was particularly influenced by the momentum generated during Belgium’s presidency of the Council of the European Union in 2024, which placed global health security at the forefront of the European agenda.
Day Two: Operational Deep Dives
The second day shifted toward empirical analysis. Participants examined the "Access to Medicines" program, utilizing Senegal as a case study for country-level implementation. The day also included a sobering review of WHO’s field work in conflict zones, specifically Gaza, which highlighted the immense challenges of maintaining health infrastructure under extreme duress. Afternoon sessions were dedicated to the "UHC-Partnership," reviewing the 2021–2024 results and assessing how to better align WHO country office programs with Belgian bilateral aid.
Day Three: Future-Proofing and Policy Synthesis
The final day was dedicated to the future of the Belgium-WHO multi-year agreement. The discussions crystallized into a shared vision for the GPW14, with a focus on mental health, neglected tropical diseases, and sexual and reproductive health and rights (SRHR). The dialogue concluded with a commitment to a renewed WHO-Belgium Country Cooperation Strategy, ensuring that the partnership remains agile in the face of "uncharted territories."
Supporting Data: Translating Commitment into Outcomes
The success of the Belgium-WHO partnership is rooted in evidence-based programming. Throughout the dialogue, the WHO presented data demonstrating the impact of Belgian support.
- Access to Medicines: The program has moved beyond simple procurement. By focusing on market shaping and local production, the partners are addressing the root causes of supply chain fragility. The Senegal example served as a proof-of-concept for how localized production can mitigate global shortages.
- UHC-Partnership (2021–2024): The review of outcomes in partner countries, notably the DRC, revealed that integrating Belgian bilateral cooperation with WHO’s technical advisory roles significantly improved the resilience of primary health care (PHC) systems.
- Health Emergencies: The discussion surrounding biological risks highlighted the necessity of the "One Health" approach. With the acceleration of zoonotic spillover events, the data suggests that investments in early warning systems and laboratory capacity in Africa—supported by Belgium—are the most cost-effective defenses against future pandemics.
Official Responses: Voices from the Table
The tone of the dialogue was one of mutual respect and candid reflection.
Mr. Koen Van Acoleyen, Minister Counselor at the Permanent Representation of Belgium to the UN, captured the sentiment of the delegation: "After listening to the leaders and experts of WHO we now better understand how they are navigating these challenging times. We are honoured that we can walk this road together."
From the WHO side, Dr. Catharina Boehme, Assistant Director-General for External Relations and Governing Bodies, emphasized the rarity of such comprehensive support: "We thank you for your support, honesty, and strong engagement for global health. Your efforts in supporting our work in Mozambique and Senegal are clear examples of the crucial work we accomplish together."
Mr. Dirk Brems, Director of Thematic and Multilateral Cooperation, echoed the need for continued collaboration: "We recognize WHO as a trustworthy partner in global health. We felt proud hearing how crucial our support is to the Organization and how it is having a positive impact at country, regional, and global levels. It’s important we continue these discussions as we tread uncharted territories."
Implications: The Road to GPW14
The implications of this strategic dialogue extend well beyond the walls of the WHO headquarters in Geneva. As the world transitions into the implementation phase of the WHO’s 14th General Programme of Work (GPW14), the Belgium-WHO partnership provides a model for how donor states can effectively support multilateralism.
1. Strengthening Multilateralism
In an era where international cooperation is often questioned, the commitment from both the Belgian federal and regional governments (Flemish and Walloon) signals a unified, whole-of-government approach to global health. This level of internal coordination is essential for providing stable, predictable, and flexible funding to the WHO.
2. The Shift to Sustainability
The emphasis on "market shaping" and "local production" for vaccines and medicines marks a fundamental shift in development philosophy. The partners are moving away from dependency-based models toward a vision of regional sovereignty, where nations in the Global South have the infrastructure to respond to their own health needs.
3. Resilience as a Primary Metric
The inclusion of mental health in the context of primary health care and the focus on biological risks (zoonoses) indicate that the partnership is expanding its definition of "health." It is no longer just about infectious disease control; it is about building health systems that are resilient to the psychological and environmental stresses of the 21st century.
4. Future Cooperation
The move toward a renewed Country Cooperation Strategy suggests that the partnership will become more localized. By aligning WHO country-level work with Belgium’s bilateral development aid, the two entities are reducing fragmentation, ensuring that every Euro spent is mapped to a specific, measurable, and sustainable health outcome.
Conclusion
The March 2025 strategic dialogue between Belgium and the WHO was more than a routine check-in; it was a reaffirmation of the belief that global health is a collective responsibility. By grounding their discussions in the realities of the field—from the hospitals of Gaza to the clinics of the DRC—Belgium and the WHO have set a standard for how strategic partnerships can be both technically rigorous and deeply human-centric. As they look toward the challenges of the next decade, this collaboration stands as a cornerstone of the global effort to achieve health for all, ensuring that no country is left to face the "uncharted territories" of future health threats alone.
About the Author
